Metraipolis › archive › dc_95f93ddbbf25

Sustained Intraocular Pressure Reduction Using Bisoprolol-Loaded PLGA Nanoparticles: A Promising Strategy for Enhanced Ocular Delivery with Reduced GFAP… — Europe PMC PMID:41304755

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41304755
DOI
10.3390/pharmaceutics17111418
License (as archived)
solo-consultazione
Archived
2026-11-08T22:08:25.829Z
SHA-256 of the archived text
a1b158d4860eab33b7357f284961c9372eefa66310eb7ce9853631bd4d543824
Stable URL of this page
https://metraipolis.com/documento/dc_95f93ddbbf25

How to cite

Sustained Intraocular Pressure Reduction Using Bisoprolol-Loaded PLGA Nanoparticles: A Promising Strategy for Enhanced Ocular Delivery with Reduced GFAP… — Europe PMC PMID:41304755 — Europe PMC (en), https://europepmc.org/article/MED/41304755 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_95f93ddbbf25 (Metraipolis archive dc_95f93ddbbf25, sha256 a1b158d4860eab33b7357f284961c9372eefa66310eb7ce9853631bd4d543824)
BibTeX
@misc{dc95f93ddbbf25,
  title = {Sustained Intraocular Pressure Reduction Using Bisoprolol-Loaded PLGA Nanoparticles: A Promising Strategy for Enhanced Ocular Delivery with Reduced GFAP… — Europe PMC PMID:41304755},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41304755},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_95f93ddbbf25; sha256 a1b158d4860eab33b7357f284961c9372eefa66310eb7ce9853631bd4d543824},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41304755. Agents can read the archived copy with the MCP tool read_document.